Cva Family Office, LLC Bio N Tech Se Transaction History
Cva Family Office, LLC
- $550 Million
- Q2 2024
A detailed history of Cva Family Office, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Cva Family Office, LLC holds 12 shares of BNTX stock, worth $1,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 11
9.09%
Holding current value
$1,016
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
325Shares Held
40.3MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.28MShares$701 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.81MShares$407 Million0.34% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$323 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$294 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$290 Million1.76% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $20.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...